MARCHing onward.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CannaDX works exactly as it's designed to and there's no other product like it and its data analytics are HIPPA compliant which is a big deal and is why I will continue posting that.
MYDX goal is transparency in the cannabis market and other markets and environments
That is why I say non-cannabis test result. The explanation cover ANY non-cannabis test.
If someone has a more accurate explanation than mine, I encourage it. But for someone to say CannaDX makes up numbers because it says a banana has THC because of the test result IS COMPLETELY PROPOSTEROUS.
I never mentioned bananas. However, people will claim they conducted a non-cannabis test and bananas has been an example. What's important are the cannabis results from CannaDX for TCP.
If it were up to MYDX, it would be trading on NASDAQ today. It's up to investors to accumulate and new investors to take advantage of sp where it is and trader to drive sp back to .01 where new investors who don't normally trade on OTC but know where MYDX is going (NASDAQ) and whose brokerage doesn't trade subpenny will be buying in for the first time and MYDX will be seeing a stimulated market when all this happens and 100s of millions of shares will be traded on consecutive days very soon. Sp will be at .05 in a matter of weeks with a stimulated market. That's the market end of it. The company is striving to give customers the opportunity to say that the current situation they are in is NOT GOOD ENOUGH, "WE WANT TRANSPARENCY" and MYDX through "trust and verify" offers customers that confidence and there is no other product on the market that can do that. NO BRAINER FOR CURRENT INVESTORS TO HOLD AND ACCUMULATE AND NO BRAINER FKR THOSE INVESTORS WAITING AT .01 THAT THEIR BUYIN WILL BE WORTH THE WAIT!!
It's important to remember, MYDX=solution to EXPOSED PROBLEM: unsafe black market weed. Before it was just black market weed, this by itself is not effective for MYDX but now that it's UNREGULATED HARMFUL BLACK MARKET WEED, the only chance consumers have of not being harmed by illegal unregulated weed is the MYDX CannaDX chemical analyzer with proven successful results! Once MYDX becomes PREMIER HOUSEHOLD CANNABIS QUALITY CONTROL backed by consumers and consumer confidence, what other companies will be around to compete? What direct competition does MYDX have?
MYDX major reasons why MYDX data is so valuable (followed by reference link):
"However, as MyDx began to analyze the data it accumulated from its testing devices, a much darker picture appeared - you cannot trust what dispensaries sell you."
"Today, if you were to go into any dispensary and ask for "Blue Dream", what do you think you would get? Would you get "Blue Dream"?
According to MyDx data, the answer is unequivocally NO!
Unfortunately, not all Blue Dreams are created equal, unveiling the biggest lie in cannabis. Whereas consumer products outside of cannabis enjoy a higher level of consistency and reliability brought on by stricter enforcement of consumer laws, the same cannot be said about the cannabis industry."
"Fortunately for MyDx users, brand names take a back seat to chemical profiles as MyDx tracks data based on sensory responses, interpreted chemical profiles, and an associated feeling or relief. So while you can't trust the brand name you purchase, you can Trust and Verify® chemical profiles and track how those profiles make you feel using MyDx, which has created another opportunity: green Active Pharmaceuticals Ingredients (gAPI)
"I believe extraction and formulation into a concentrate that can be delivered consistently to help patients find relief for their ailments and symptoms is the next logical step to achieving some level of consistency in the industry," stated Daniel Yazbeck, Chief Executive Officer of MyDx."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
MYDX Why gAPI is so valuable (link reference to follow):
"...we are now identifying the specific green Active Pharmaceutical Ingredients (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy. This information not only supports an active engaged community, but also provides the basis for our Company to partner, sell and supply smart devices and formulations to the various communities we service so they can benefit from tailored cannabis therapies that meet their specific needs."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
MYDX is HIPPA compliant, important? You be the judge after considering the following (reference links to follow):
"We are finally getting to the heart of what ailments people are tracking and more importantly, what unique chemicals profiles are helping them find relief," stated Yazbeck. "By mining this HIPPA Compliant Data, we are now identifying the specific green Active Pharmaceutical Ingredients (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
Is HIPPA compliance important (reference link to follow)?
"When dealing with patient ePHI, having a HIPAA compliant provider offers practitioners multiple benefits and peace of mind against impending audits."
http://blog.corespace.com/the-benefits-of-a-hipaa-compliant-provider
Is this product helping consumers determine whether or not they want to smoke a certain strain of cannabis before they smoke it? Is this product helping consumers communicate with MYDX verification that a certain strain could have a certain effect for someone interested in similar results as research before they invest in a cannabis purchase? The answer to these quintessential questions is undoubtedly YES and this is what I love about MYDX and what it is doing for consumers through CannaDX. Big deal if someone tells me a certain strain works for them, I want to be able to test it for myself. MYDX will allow me to test a strain I've had that made me feel sick and caused vomiting and dizziness. I love that I will be able to test what strain that was so I know through the "trust and verify" process that I will never put that strain in my body ever again! This is just cannabis, MYDX is so much more but what it accomplishes is exactly what it set out to do from day one and that is allow consumers the opportunity to "trust and verify" something before they expose it to their bodies, and as far as AeroDX, I believe, there will be sensors you can place in a room that will monitor the air so that before someone enters it, they will be able to know if the air is toxic. For sure, if a room's air is toxic after you enter it, AeroDX will let you know. If someone hates this product or company, it can't be for these reasons, so that's what I will never understand about people who say they hate this company and products. I'm not going to ask questions leading to the conclusion that people involved in companies such as big pharma just don't want MYDX to succeed because it is a threat to their market share in their industry.
Even lab tests produced different results for samples of same cannabis flower. The important thing is that MYDX has a product that through the electronic nose nanotechnology in conjunction with an algorithm that is able to formulate accurate results from a sample and provide the consumer with the TCP. There was a huge fog over the legitimacy of the process about how non-cannabis can produce a THC% but the fact remains that the non-cannabis test samples do not have THC and I believe the only reason they produce a THC% is because of the algorithm. Even though the non-cannabis test sample was analyzed and determined to have a "0" factor it could still be given an overall % value as explained previously due to the algorithm. It's a very complex system of technolgy but it works and is accurate. It's important for the consumer not to misuse the device. Tests conducted at different labs resulted in high variance in test results and labs are trusted today. It is important for consumers to "trust and verify" with MYDX's CannaDX due to the margin of error of chemical breakdown on labeled product at dispensaries. For products that are not labeled with a chemical breakdown, it is that more important to "trust and verify".
If someone conducted an experiment with a "0" factor non-cannabis consumable, then yes, the result of test will be greater than 0%, such as 20% because of the complex algorithm. It's common knowledge that a banana has 0% THC and even though it's a "0" factor, it becomes 20% as previously explained.
Possible explanation for why non-cannabis tests come outwitha%THC: There are so many legitimate sample tests conducted and data collected and I'm no scientist nor mathematician and I have no idea how the algorithm works but it is very curious to me why THC% would result in a test with a non-cannabis product. Here's the simplest way I could explain a quite complex matter: Students get a final grade in a subject based on attendance, homework, projects, participation, and exams. Each of these sections has a weighted-average. Exams tend to be 40-50% of final grade and homework tends to be 20-30%, projects 25-30% and attendance and participation make up 5-10%. For this example, all percentages total 100% but the heaviest is exams and let's use THC in place of exams in the final TCP. Of course, running a non-cannabis sample has 0% THC, that is common sense. However because of the algorithm, when a factor of "0" goes in for the total weighted average of every test conducted, what is known to be "0%" now has a number higher than 0%. For example, 10+10+10+10=40; 40/4=10 each unit remaining the same, 10. However, add a "0" to the equation add and divide and you get a skewed result and the "0" factor becomes a number higher than "0". 10+10+10+10+0=40;
40/5=8 so the value of "0" has now become "8" or 20% of total and I believe this is how 0% THC becomes an actual number higher than "0" However, the algorithm is so complex and science is so complex and the number of tests conducted is so high that every once in awhile a curious person is bound to put a "0" factor in the compartment and run a test that results in a THC% higher than zero and I believe this explains why it does.
If I wanted to look at cannabis before purchasing, I would be ok with pictures online or viewing behind the glass, but that is not a sufficient inspection before buying much less smoking.
This particular Canadian dispensary https://weedsgg.ca/shop/product/jack-ak-933 does not show chemical breakdown on website, how does the customer really know what it is buying? I would want to "trust & verify" before smoking this strain to show its TCP. I believe they would let patrons who buy on site "trust & verify" according to this: (website to follow)
"We operate retail stores at over 17 locations across Canada where you can see our beautiful glass in person, inspect our product before you purchase; and be helped by knowledgeable staff." Inspect product to me means "trust and verify."
https://weedsgg.ca/page/homepage
MYDX SHORTERS ENRICHMENT SCHEME=GRABBING INVESTOR SHARES BUT NO INVESTORS SELLING 2017
I am open to conversation with anyone.
Anyone selling their investment position under .025 is selling their investment and themselves short.
.25 is a good leaping pad from an investors perspective today. Reverse split at .25 is not a threat for investors. By then, MYDX will have at least 90% support of investors and with NASDAQ on the horizon at .25, a reverse split may not even be a necessity.
Investors have a unique outlook on companies they invest in and rare is there a company that is traded on the OTC worth the risk for an investor because everyone knows OTC is the livelihood for traders and shorters and investors are a threat to shorters who have a lot at risk that benefits from the failure of companies. MYDX proving to be a successful company despite financials means is reflected in investor confidence. 100s of millions of shares are being held by investors with a unique outlook. Investors are not shaken by sorta, kinda, maybe, alleged accusations. Investors know where MYDX is going and will prove to be worth the wait when market is stimulated. 10MILLION shares is nothing in the eyes of investors at .004. The market is obviously not stimulated. MYDX was trading 1 million shares a minute on average in the first 30 minutes of open in March. Market was clearly stimulated then and clearly is not stimulated now. Q2 financials could be the catalyst for market stimulation or something revealing solid product sales beforehand other than the fact that CannaDX is continuing to increase in value on a daily basis due to continued "trust and verify" process by consumers.
A reverse split is always a possible necessary step to uplist, however, if MYDX achieves .25 without a reverse split by 2018, there is no reason to believe a reverse split is necessary at that point. By then there would be substantial investor support and what was once a traders and shorters feeding ground is now in 90% investors holding and selling at profits and over time drives the price higher and will get the attention of investment companies looking to diversify their portfolio for long term growth.
Anyone who bought in at .01 and didn't sell at .022 seem to be investors waiting for 2018 and beyond, otherwise shares would have been sold in the .02's. Anyone uncertain about their investment with sp dropping back to .015 would have sold, anyone who didn't sell at that point and hasn't sold through today is still waiting for 2018 and beyond. This is my insight for I am an investor who bought at .01 all the way up to .022 and will not sell until 2018 and beyond. I believe today what I believed when I made my first investment, MYDX will be trading at .25 in 2018 and is NASDAQ bound.
CustomerA buys CannaDX. With CannaDX, CustomerA runs a sample test of cannabis purchased at a dispensary. CustomerA produces the TCP on the APP and corresponds how smoking the cannabis made the customer feel. CustomerA now becomes ConsumerA. ConsumerA repeats this process with every different sample test AKA "trust & verify" for all who have the APP to observe and then tells someone else about CannaDX AKA "word of mouth" and now CustomerB is created and continues the process from where CustomerA began. This snapshot is also referred to as "organic marketing", this is what has helped build the solid foundation of marketable catalogued sample tests from consumers through the "trust & verify" process. This catalogue is similar to other companies catalogues of uploaded strain and feeling correlations except that MYDX is the only company to offer a device (CannaDX) for consumers to actually "trust & verify" what product they are about to consume. OrganaDX will prove to be an extension of the CannaDX in that consumers will sample test not only cannabis but virtually anything edible for banned pesticides that are harmful to the body. All MYDX can do is offer products the public needs to maintain confidence in products that is earned and restore confidence that is lost.
With the solid platform created through "word of mouth" MYDX determined CannaDX is ready for market campaign: Canada, from Canada, it will be interesting to see the next step. Perhaps the new sensors will be marketed in Canada before CannaDX is marketed further directly in other countries. Of course, word gets around freely, and fast if it's great.
MYDX PROVEN SUCCESSFUL BY CONSUMER BUY/HOLD/TEST&VERIFY CYCLE
MYDX TRUST&VERIFY=CANNABIS CONSUMER CONFIDENCE
MYDX-BACKED CANNABIS INDUSTRY=GROWER/DISPENSARY TRANSPARENCY=CONSUMER CANNABIS CONFIDENCE
MYDX INVESTORS WATCHING STRONG CLOSE=BEGINNING POSITIVE TREND
SHORTERS ENRICHMENT SCHEME=GETTING INVESTORS SHARES
STIMULATED MARKET=1MILLION SHARES TRADED/MINUTE/1ST 30MINUTES AFTER OPEN
UNSTIMULATED MARKET=LOW VOLUME ONLY 10MILLION SHARES TRADED
MYDX MOVING FORWARD WITH GOOD DEALS
MYDX PREDICTS HOW USER WILL FEEL BASED ON INDIVIDUAL SAMPLE TESTS CONDUCTED BY INDIVIDUAL CONSUMER RESULTS...MYDX DOES PROVIDE ACCURATE TCP RESULTS AND BASED ON USER FEELINGS OF CERTAIN ACCURATE TCP RESULTS FROM CONSUMER USERS, MYDX CAN PREDICT FEELINGS BEFORE USE, IT DOES NOT PREDICT TCP, TCP IS THE ACCURATE RESULT FROM A SAMPLE TEST USING CANNADX
INVESTOR BUYING AND TRADERS TRADING IN SOON TO BE STIMULATED MARKET AFTER FINANCIALS WILL DRIVE SP TO 10x+ IN A MATTER OF WEEKS
MYDX GREAT BUYING OPPORTUNITY FOR INVESTORS TO BUY NOW AND ITS WORTH THE WAIT FOR .01 TO BUYIN...MYDX INVESTORS EXPECT .25 BY END OF 2018...NO INVESTORS SELLING 2017...BUYING IN UNDER .025 IS WORTH THE WAIT.
MYDX MOVING FORWARD IN RIGHT DIRECTION
MYDX: MUST HAVE HOUSEHOLD PRODUCT FOR REGULAR CANNABIS SMOKERS. IT IS RESPONSIBLE TO TRACK USAGE AND HELP OTHERS IN THE PROCESS.
TODAYS SCHEDULE FOR SHORTERS: .00351. INVESTORS DONT GET DUPED INTO SELLING, SHORTERS ARE TRYING TO GET YOUR SHARES BEFORE FINANCIALS ARE RELEASED.
INVESTORS WAITING AT .01 TO BUY IN BECAUSE YOU DON'T NORMALLY INVEST IN OTC AND YOUR BROKERAGE DOESN'T TRADE SUBPENNY: IVE BEEN WHERE YOU ARE AND IT IS WORTH THE WAIT. CURRENT INVESTORS ARE NOT SELLING 2017 AND ARE LOOKING AT .25 BY END OF 2018. ANYTHING BOUGHT UNDER .025 IS WORTH THE WAIT.
Apparently, growers and dispensaries are already doing their thing in business, why would they dilly dally with MYDX until regulation improves then they will be needing MYDX AND PAYING FOR IT? It's the consumers buying products at dispensaries who have the responsibilty to "trust and verify" that what they smoke is what they intended. DISPENSARIES DO NOT TEST EACH PRODUCT SOLD. THEY LABEL EACH PRODUCT FROM ONE BULK SAMPLE TEST WHICH LEAVES ROOM FOR A MARGIN OF EARROR. CONSUMERS HAVE THE RIGHT TO "TRUST AND VERIFY" AND MYDX IS THE SOLUTION.
That is correct. Interesting. Sp is also 10x at market cap only 3x.
MYDX SHORTERS SCHEDULE FOR NEXT 5 TRADING DAYS. THIS IS FIGURING 10% DELIBERATE DECREASE IN SP ON A DAILY BASIS ALLOWABLE BY LAW: .00351, .003159, .0028431, .0025588, .002303
INVESTORS, DO NOT BE DUPED INTO SELLING, THIS IS A VERY TEMPORARY SCHEDULE, THIS WILL NOT CONTINUE MUCH LONGER.
IM HERE TO OFFER FACTS NOT MAYBE SORTA ALLEGED JUNK. IM NOT HERE TO ANSWER ALL QUESTIONS, THE COMPANY WILL BE HAPPY TO DO ALL THAT.
FACT: ACTUAL PURCHASED CANNABIS PRODUCTS AT DISPENSARIES ARE LABELED FROM ONE SINGLE SAMPLE OF A BULK SUPPLY LEAVING A MARGIN OF ERROR WHEN BROKEN DOWN INTO PARTS AND BECAUSE DISPENSARIES ARE GETTING AWAY WITH LABELING EACH PRODUCT AS THE INITIAL SINGLE BULK TEST, IT IS THE CONSUMERS RESPONSIBILTY TO "TEST & VERIFY" A SAMPLE OF THEIR PURCHASE BEFORE SMOKING IT.
WITH THE RELEASE OF ORGANADX, IT WILL BE THE CONSUMERS RESPONSIBILTY TO "TRUST & VERIFY" A SAMPLE OF THE CANNABIS BEFORE SMOKING IT BECAUSE DUE TO A SLACK IN INDUSTRY REGULATION, THERES A CHANCE THE CONSUMER CAN BE HARMED BY UNAPPROVED PESTICIDES AND THAT IS A RISK NO CONSUMER SHOULD BE FACED WITH AND MYDX HAS THE SOLUTION FOR THAT AS WELL.